Rothschild Investment Corp Compugen LTD Transaction History

Rothschild Investment Corp

$1.19 Billion
Q3 2023

A detailed history of Rothschild Investment Corp transactions in Compugen LTD stock. As of the latest transaction made, Rothschild Investment Corp holds 351,100 shares of CGEN stock, worth $639,002. This represents 0.03% of its overall portfolio holdings.

Number of Shares

351,100

Previous 343,600 2.18%

Holding current value

$639,002

Previous $380,000 16.05%

% of portfolio

0.03%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 16, 2023	BUY	$0.88 - $1.31 $6,600 - $9,825	7,500 Added 2.18%	351,100 $319,000
Q2 2023 Jul 18, 2023	SELL	$0.57 - $1.38 $10,329 - $25,008	-18,122 Reduced 5.01%	343,600 $380,000
Q1 2023 Apr 24, 2023	SELL	$0.68 - $1.11 $2,705 - $4,415	-3,978 Reduced 1.09%	361,722 $254,000
Q4 2022 Jan 19, 2023	SELL	$0.65 - $1.2 $16,250 - $30,000	-25,000 Reduced 6.4%	365,700 $251,000
Q3 2022 Oct 21, 2022	SELL	$0.77 - $2.32 $12,089 - $36,426	-15,701 Reduced 3.86%	390,700 $257,000

Q2 2022 Jul 12, 2022	SELL	$1.57 - $3.33 $25,120 - $53,280	-16,000 Reduced 3.79%	406,401 $752,000
Q1 2022 Apr 18, 2022	SELL	$2.76 - $4.64 $73,692 - $123,887	-26,700 Reduced 5.95%	422,401 $1.43 Million
Q4 2021 Jan 24, 2022	SELL	$4.09 - $7.16 $37,628 - $65,872	-9,200 Reduced 2.01%	449,101 $1.93 Million
Q3 2021 Oct 12, 2021	BUY	$5.8 - $8.02 $253,750 - $350,875	43,750 Added 10.55%	458,301 $2.74 Million
Q2 2021 Jul 19, 2021	BUY	$6.87 - $9.16 $121,599 - $162,132	17,700 Added 4.46%	414,551 $3.43 Million
Q1 2021 Apr 15, 2021	BUY	$7.67 - $13.77 $178,711 - $320,841	23,300 Added 6.24%	396,851 $3.41 Million
Q4 2020 Jan 25, 2021	BUY	$12.07 - $17.95 $72,420 - $107,700	6,000 Added 1.63%	373,551 $4.52 Million
Q3 2020 Oct 22, 2020	BUY	$14.16 - $19.45 $363,204 - $498,892	25,650 Added 7.5%	367,551 $5.97 Million
Q2 2020 Jul 24, 2020	SELL	$6.97 - $17.12 $9,758 - $23,968	-1,400 Reduced 0.41%	341,901 $5.14 Million
Q1 2020 Apr 16, 2020	BUY	$5.79 - $11.83 $7,237 - $14,787	1,250 Added 0.37%	343,301 $2.49 Million
Q4 2019 Jan 22, 2020	BUY	$3.9 - $6.16 $31,395 - $49,588	8,050 Added 2.41%	342,051 $2.04 Million
Q3 2019 Oct 11, 2019	SELL	$3.01 - $4.49 $42,742 - $63,758	-14,200 Reduced 4.08%	334,001 $1.41 Million
Q2 2019 Jul 11, 2019	SELL	$2.8 - $4.14 $37,940 - $56,096	-13,550 Reduced 3.75%	348,201 $1.34 Million
Q1 2019 Apr 18, 2019	SELL	$2.35 - $4.19 $3,760 - $6,704	-1,600 Reduced 0.44%	361,751 $1.5 Million
Q4 2018 Jan 28, 2019	SELL	$2.17 - $3.8 $100,905 - $176,700	-46,500 Reduced 11.35%	363,351 $788,000
Q3 2018 Oct 17, 2018	SELL	$3.0 - $4.05 $16,800 - $22,680	-5,600 Reduced 1.35%	409,851 $1.58 Million
Q2 2018 Jul 24, 2018	BUY	$3.15 - $4.7 $24,570 - $36,660	7,800 Added 1.91%	415,451 $1.37 Million
Q1 2018 Apr 27, 2018	BUY	$2.5 - $4.45 $14,250 - $25,365	5,700 Added 1.42%	407,651 $1.74 Million
Q4 2017 Jan 23, 2018	SELL	$2.35 - $4.0 $102,577 - $174,600	-43,650 Reduced 9.8%	401,951 $1.01 Million
Q3 2017 Oct 25, 2017	BUY	$2.75 - $3.95 $1.23 Million - $1.76 Million	445,601	445,601 $1.69 Million

Others Institutions Holding CGEN

# of Institutions

Shares Held

13.7M

Call Options Held

131K

Put Options Held

76K

View Full List

About COMPUGEN LTD

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $158M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

More about CGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment Corp , based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment Corp with notifications on news.

Account

Rothschild Investment Corp Compugen LTD Transaction History